Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fan Tong

Showing results (201-210 of 212) with videos related to

Pageof 22
Sort By:
Chinese Medicine|February 23, 2022
Tea and tea drinking: China's outstanding contributions to the mankindSi-Yuan Pan, Qu Nie, Hai-Chuan Tai, et al.
Iscience|August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLCLianxi Song, Liang Zeng, Qinqin Xu, et al.
Chinese Medical Journal|March 3, 2011
Molecular basis of von Hippel-Lindau syndrome in Chinese patientsWai-Kwan Siu, Ronald Ching-Wan Ma, Ching-Wan Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoringJiayao Ni, Yi Sun, Hao Cheng, et al.
Chinese Medical Journal|February 19, 2025
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitorsLianxi Song, Qinqin Xu, Ting Zhong, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2021
A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activationGang Chen, Yi Wang, Xin Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
World Journal of Pediatrics : WJP|March 16, 2022
Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening expertsFan Tong, Jian Wang, Rui Xiao, et al.
Pageof 22

Showing results (201-210 of 212) with videos related to

Sort By:
Pageof 22
Chinese Medicine|February 23, 2022
Tea and tea drinking: China's outstanding contributions to the mankindSi-Yuan Pan, Qu Nie, Hai-Chuan Tai, et al.
Iscience|August 20, 2025
Lymphocyte subset-based non-invasive biomarker predicts immunochemotherapy efficacy in EGFR-TKI-pretreated EGFR-mutated NSCLCLianxi Song, Liang Zeng, Qinqin Xu, et al.
Chinese Medical Journal|March 3, 2011
Molecular basis of von Hippel-Lindau syndrome in Chinese patientsWai-Kwan Siu, Ronald Ching-Wan Ma, Ching-Wan Lam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 1, 2025
Tislelizumab and hypofractionated radiotherapy plus nab-paclitaxel/gemcitabine as conversion therapy for BRPC/LAPC: A Phase II trial with dynamic biomarker monitoringJiayao Ni, Yi Sun, Hao Cheng, et al.
Chinese Medical Journal|February 19, 2025
Potential utility of albumin-bilirubin and body mass index-based logistic model to predict survival outcome in non-small cell lung cancer with liver metastasis treated with immune checkpoint inhibitorsLianxi Song, Qinqin Xu, Ting Zhong, et al.
Cancer Immunology, Immunotherapy : CII|March 7, 2024
Clinical evidence for efficacy of pembrolizumab in MSI-H and TMB-H advanced solid tumor: results from three cancer centers in ChinaHuan Yan, Lianxi Song, Yizhi Li, et al.
Lung Cancer (Amsterdam, Netherlands)|May 25, 2024
Clinical treatment patterns, molecular characteristics and survival outcomes of ROS1-rearranged non-small cell lung cancer: A large multicenter retrospective studyZhe Huang, Yuda Zhang, Qinqin Xu, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 1, 2021
A positive feedback loop between Periostin and TGFβ1 induces and maintains the stemness of hepatocellular carcinoma cells via AP-2α activationGang Chen, Yi Wang, Xin Zhao, et al.
Lung Cancer (Amsterdam, Netherlands)|August 2, 2025
Comprehensive first-in-human phase I/II study of FHND-9041 in patients with EGFR-mutated advanced non-small cell lung cancerLiang Zeng, Fan Tong, Xingxiang Xu, et al.
World Journal of Pediatrics : WJP|March 16, 2022
Application of next generation sequencing in the screening of monogenic diseases in China, 2021: a consensus among Chinese newborn screening expertsFan Tong, Jian Wang, Rui Xiao, et al.
Pageof 22